UBE-1099

N/A

Report date: 2024/12/18 15:50:30
NME

Base Information

Drug NameUBE-1099
Drug Alias NameUBE-1099UBE1099
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKelch-like ECH-associated protein 1 modulatorsNuclear factor erythroid 2-related factor 2 modulators
TargetsKelch-like ECH-associated protein 1Nuclear factor erythroid 2-related factor 2
Therapy Area/IndicationsRenal Insufficiency, ChronicGlomerulosclerosis, Focal Segmental
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKumamoto University
China Registration ClassN/A

Develop Information

Active CompaniesKumamoto University
Inactive CompaniesN/A
Active IndicationsRenal Insufficiency, ChronicGlomerulosclerosis, Focal Segmental
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A